Kay Warner is a Senior Director within the Patients in Partnership team at GlaxoSmithKline Research and Development and is a patient engagement subject matter expert at GSK. With her passion to make a difference in research and development, Kay has spent the last 16 years of her career working to strengthen the patient voice in medicines development and research at key decision time points. Her work has included interaction with individual patients, caregivers, patient advocates, patient advocacy organisations and health care providers. She also represents GSK in the European Patients’ Academy (EUPATI) project. She is also supporting the IMI2 project Patients Active in Research and Dialogues for an Improved Generation of Medicines (PARADIGM).

Organizations

GlaxoSmithKline

Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for our patients and consumers and make GSK a brilliant place to work. Our values are Patient focus, Transparency, Respect, Integrity. Our expectations are Courage, Accountability, Development, Teamwork. We have 3 global businesses that research, develop, and manufacture innovative pharmaceutical medicines, vaccines, and consumer healthcare products. Our goal is to be one of the world’s most innovative, best performing, and trusted healthcare companies.